Lung Nodule Assessment and Comparison Option (LNA)
K-Number: K162484 · 2017-02-23
Device Summary
Frequently Asked Questions
What is the Lung Nodule Assessment and Comparison Option (LNA)?
Lung Nodule Assessment and Comparison Option (LNA) is a medical device that received FDA 510(k) clearance on 2017-02-23. The listed applicant is Philips Medical Systems Nederland B.V.. The 510(k) number is K162484.
When did Lung Nodule Assessment and Comparison Option (LNA) receive FDA 510(k) clearance?
Lung Nodule Assessment and Comparison Option (LNA) received FDA 510(k) clearance on 2017-02-23, under 510(k) number K162484.
Who is the listed applicant for Lung Nodule Assessment and Comparison Option (LNA)?
The FDA 510(k) record lists Philips Medical Systems Nederland B.V. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Lung Nodule Assessment and Comparison Option (LNA)?
The FDA product code for Lung Nodule Assessment and Comparison Option (LNA) is LLZ.
Other records listing Philips Medical Systems Nederland B.V. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LLZ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.